The Tale of Big Pharma- Bayer (IG Farben), FDA and the AIDS virus
Written By: Milos Pokimica
Medically Reviewed by: Dr. Xiùying Wáng, M.D.
Updated August 4, 2023Nutritional science explained all of the connections between diseases of affluence and animal food consumption decades ago. Most of our number one killers are preventable but there is no interest in changing the current line of business. All of the available science will be kept out of the public and in reality, it does not matter.
What most people are aware of is just propaganda. Doctors are good, they have to pledge a Hippocratic oath, there are there to heal you and help you, and of course one day medicine is going to deliver us from all diseases. Usually, when people are confronted with the real history behind big pharma and realize the truth that government itself has a network for suppressing the science and that individual men’s interest is not its primary goal, they usually say that it is all in the past. Today we have more democracy and freedoms with better governmental control and so on.
The answer is no. We have even fewer freedoms than after WW2. We have been brainwashed in schools and by the media infused with psychological research for social control, but nothing else is different. The same structure exists and has been existing from not just middle age but even before that.
I will give one more recent example. You’d probably never know that Bayer (IG Farben) paid “tens of millions” of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood products to hemophiliacs, thousands of whom later died of AIDS. Bayer is eventually forced into signing checks to individuals that acquired AIDS because, in the 1980s, the Cutter Biological section of Bayer neglected federal law and recruited gay men with high risk and intravenous drug users, and prisoners as donors of the blood that Cutter later used to produce Factor VIII and IX. It is a drug, the clotting product, that hemophiliacs need in order to not bleed to death. In 1997 Bayer was sentenced to pay 600 million into a compensation fund for hemophiliacs with HIV. About 20,000 individuals caught HIV from the blood.
Ironically, Bayer’s new hemophilia iPhone app got some coverage, as did Bayer’s hemophilia research grant to the University of Florida.
On July 16, 1982, the United States Centers for Disease Control and Prevention (CDC) suggested that three hemophiliacs had acquired AIDS. Epidemiologists began to think that the virus was spreading through hemophiliac medication that they inject once every week. Medication was made from large pools of donated plasma from different people. Much of which was collected before mandatory HIV testing, often from homosexuals and drug users and in some prisons. Without an infection test, they had no way to determine does the plasma donors carried the virus. In January 1983, the manager of Bayer’s Cutter Biological department confirmed in a letter that:
“There is strong evidence to suggest that AIDS is passed on to other people through … plasma products.”
These letters surfaced in trials and were found by some of the investigative journalists that later broke the story public. By May 1983, a Cutter competitor started producing a heat-treated concentrate that killed the virus, so France for example, and many other countries decided to halt all clotting concentrate imports. Cutter worried about losing consumers, so according to an enclosed memo: “want to give the impression that we continue improving our product without telling them that soon we were also going to have a heat-treated” concentrate. By June 1983, a Cutter letter to distributors to 20 countries said that:
“AIDS has become the center of irrational response in many countries” and that “This is of particular concern to us because of unsubstantiated speculations that certain blood products may transmit this syndrome.”
They lied, and many countries were still using an old concentrate. In February 1984, Cutter became the last of the four major blood product companies to get US approval to sell heated concentrate. They waited as long as possible. Still even after Cutter started to sell the new product, still for several more months, they continued making the old medicine. The reason was that the corporation had several fixed-price contracts and thought that the old product would be cheaper to produce. Bayer officials (responding on behalf of Cutter) responded with another lie: “because some customers doubted the new drug’s effectiveness,” some nations were slow to support registration of the new drug. Then they lied by telling that they had a shortage of plasma, which is used to make the medicine. For example, Taiwan was one country that still received the old HIV-infected drug. Hsu Chien-wen, an official at Taiwan’s health department, told in 2003 that Cutter had not appealed for approval to sell the heated medicine until July 1985. That was for an entire year and a half after doing so in the United States. In Hong Kong, for example, Cutter did not even need approval but only an import license in the 1980s to be able to import and sell the newer product in which normally takes one week. A company meeting notes that:
“There is excess inventory,”
that, in reality, produced the company resolving to:
“Review international markets again to determine if more of this product can be sold.”
Because of the lack of control and corruption Cutter decided to dispose of stockpiles of older HIV-positive drugs to third world countries while selling the new, safer product in the West. If some of the people catch AIDS well, they can take Aspirin for pain. And of course, there are all third world countries, so it is going to go well with eugenic programs of depopulation of the planet. When hemophiliacs in Hong Kong all of the sudden start to test positive for HIV, local physicians raised the question of whether Cutter was dumping “AIDS tainted” medicine into less-developed countries. Cutter rejected the accusation, insisting that older drug had “no severe hazard risk” and was, in fact, the “same fine product we have supplied for years.” Hong Kong did not believe the lie, and when the local distributor asked for the newer product, Cutter responded that all of the new product was going to the US and Europe. For Hong Kong, and other third-world countries they could make an exception for a small amount for the “most vocal patients.” Meaning influential people that could potentially make a problem for them. So if you are a son of a politician, they will give you new safe stuff.
The United States Food and Drug Administration helped to keep the news out of the public eye. Government is not there to protect you and never had been. In May 1985, the FDA’s regulator of blood products, Harry M. Meyer Jr., considering the companies had violated a voluntary arrangement to remove the old drug from the market, called directors of the corporations and directed them to comply. Cutter’s internal notes from their meeting show that Meyer required that the issue is:
“Quietly solved without alerting the Congress, the medical community and the public”
also noted that the FDA wanted the matter solved “quickly and quietly.” Also at that time, Cutter official wrote that:
“It appears there are no longer any markets in the Far East where we can expect to sell substantial quantities of nonheated-treated medicine.”
They sell AIDS-tainted medicine as long as possible with no empathy. The effects of all of this are impossible to calculate because there was no test for HIV, so we do not know how many people were infected with HIV before Cutter began selling its safer medicine or afterward. Cutter also sold the old medicine in Argentina, Indonesia, Japan, Malaysia, and Singapore after February 1984. Cutter shipped more than 100,000 vials of unheated concentrate, worth more than $4 million after it began selling the safer product. The sales continued partly because of Cutter’s desire to deplete stocks of the older medicine, and partly because of fixed-price contracts, for which the company believed the older product would be cheaper to make. U.S. Justice Department had never investigated any corporate executives. Bayer in the past even marketed heroin for children. That is the level of psychopathic nature of these people.
References:
Passages selected from a book: Pokimica, Milos. Go Vegan? Review of Science Part 2. Kindle ed., Amazon, 2018.
- McHenry L, Khoshnood M. Blood money: Bayer’s inventory of HIV-contaminated blood products and third world hemophiliacs. Account Res. 2014;21(6):389-400. doi: 10.1080/08989621.2014.882780. PMID: 24785997.
- Josefson D. Haemophilia patients launch action against Bayer over contaminated blood products. BMJ. 2003 Jun 14;326(7402):1286. doi: 10.1136/bmj.326.7402.1286-g. PMID: 12805147; PMCID: PMC1151015.
Related Posts
Do you have any questions about nutrition and health?
I would love to hear from you and answer them in my next post. I appreciate your input and opinion and I look forward to hearing from you soon. I also invite you to follow us on Facebook, Instagram, and Pinterest for more diet, nutrition, and health content. You can leave a comment there and connect with other health enthusiasts, share your tips and experiences, and get support and encouragement from our team and community.
I hope that this post was informative and enjoyable for you and that you are prepared to apply the insights you learned. If you found this post helpful, please share it with your friends and family who might also benefit from it. You never know who might need some guidance and support on their health journey.
– You Might Also Like –
Learn About Nutrition
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Medical Disclaimer
GoVeganWay.com brings you reviews of the latest nutrition and health-related research. The information provided represents the personal opinion of the author and is not intended nor implied to be a substitute for professional medical advice, diagnosis, or treatment. The information provided is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH GoVeganWay.com
NEVER APPLY ANY LIFESTYLE CHANGES OR ANY CHANGES AT ALL AS A CONSEQUENCE OF SOMETHING YOU HAVE READ IN GoVeganWay.com BEFORE CONSULTING LICENCED MEDICAL PRACTITIONER.
In the event of a medical emergency, call a doctor or 911 immediately. GoVeganWay.com does not recommend or endorse any specific groups, organizations, tests, physicians, products, procedures, opinions, or other information that may be mentioned inside.
Editor Picks –
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Latest Articles –
Plant Based News
-
Protein Found In Meat Linked To Increased Risk Of Arthritis
on April 12, 2024
-
Try This Easy Quinoa And Edamame Salad
on April 12, 2024
-
Switzerland’s Inaction On Climate Crisis Breaches Human Rights, Says Landmark Court Case
on April 12, 2024
-
Eat At Least 75% Plant-Based Foods, Say Germany’s New Dietary Guidelines
on April 12, 2024
-
Don’t Believe The Myths: The Horse Racing Industry Is Rotten To Its Core
on April 12, 2024
-
South Africa Rules That Vegan Meat Cannot Be Seized From Supermarket Shelves
on April 11, 2024
-
Kale Is One Of The Best Foods We Can Eat – 10 Recipes To Try
on April 11, 2024
Top Health News — ScienceDaily
- Inherited predisposition for higher muscle strength may protect against common morbiditieson April 12, 2024
A study showed that a genetic predisposition for higher muscle strength predicts a longer lifespan and a lower risk for developing common diseases. This is a highly comprehensive international study on hereditary muscle strength and its relationship to morbidity. The genome and health data of more than 340,000 Finns was used in the research.
- A novel machine learning model for the characterization of material surfaceson April 12, 2024
Machine learning (ML) enables the accurate and efficient computation of fundamental electronic properties of binary and ternary oxide surfaces, as shown by scientists. Their ML-based model could be extended to other compounds and properties. The present research findings can aid in the screening of surface properties of materials as well as in the development of functional materials.
- Scientists uncover a missing link between poor diet and higher cancer riskon April 12, 2024
A research team has unearthed new findings which may help explain the connection between cancer risk and poor diet, as well as common diseases like diabetes, which arise from poor diet. The insights gained from this study hold promise for advancing cancer prevention strategies aimed at promoting healthy aging.
- PFAS exposure from high seafood diets may be underestimatedon April 12, 2024
A study suggests that people with diets high in seafood may face a greater risk of exposure to PFAS — the family of human-made toxins known as ‘forever chemicals’ — than previously thought. The researchers stress the need for more stringent public health guidelines that establish how much seafood people can safely consume to limit their exposure, particularly in coastal areas where seafood is frequently eaten.
- Choosing sugary drinks over fruit juice for toddlers linked to risk of adult obesityon April 12, 2024
Consuming sugar-sweetened drinks in the first few years of childhood can be linked to poor diet patterns that increase the risk of obesity in later life, according to a new study.
- Melanomas resist drugs by ‘breaking’ geneson April 12, 2024
A study has disentangled the mechanisms behind one of the ways melanoma cancer cells develop resistance to treatment. The study found that, in response to some drugs, melanomas can ‘break’ parts of their BRAF gene, which is mutated in 1 in 2 melanomas. This helps the tumor create alternative versions of the protein which lack regions targeted by one BRAF inhibitors, one of the main drugs used to treat this type of cancer, making treatment less effective. The findings pave the way for […]
- Cells putting on a faceon April 12, 2024
Neural crest cells — embryonic pluripotent cells within the facial primordium — may be necessary for forming proper animal facial structures. Researchers have produced neural crest cell-rich aggregates from human pluripotent stem cells and developed a method to differentiate them in cell populations with a branchial arch-like gene expression pattern.
PubMed, #vegan-diet –
- Changes in the consumption of isoflavones, omega-6, and omega-3 fatty acids in women with metastatic breast cancer adopting a whole-food, plant-based diet: post-hoc analysis of nutrient intake data…on April 5, 2024
CONCLUSION: Transitioning to a WFPB diet resulted in significantly increased isoflavone intake and decreased n-6:n-3 ratio in women with breast cancer.
- A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomeson March 30, 2024
CONCLUSIONS: Significant dietary changes in this population are feasible and may improve QOL by improving treatment-related symptoms. Additional study is warranted.
- Restrictive Diets in Patients with Fibromyalgia: State of the Arton March 28, 2024
Around 20-30% of Fibromyalgia patients modify their dietary habits after diagnosis, including avoiding certain food groups such as cereals. In this systematic review, we used the PRISMA guidelines to select the main studies that have evaluated the effectiveness of restrictive diets, including elimination and vegetarian diets, in patients with Fibromyalgia. Data on vegetarian/vegan diets are more consistent than data on elimination diets due to higher quality and better results of the […]
- Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Dietson March 28, 2024
CONCLUSIONS: The significantly lower omega-3 LCPUFA dietary intakes in the vegan diets were associated with higher scores in the second-order attentional aspect of self-reported impulsiveness.
- Impact of iodine supply in infancy and childhoodon March 28, 2024
PURPOSE OF REVIEW: To assess the most relevant articles on the impact of iodine supply in at-risk populations, namely infants and young children, pregnant and lactating women.
Random Posts –
Featured Posts –
Latest from PubMed, #plant-based diet –
- Fruit Quality Assessment of Novel Hybrid Pummelo × Sweet Orange and Its Molecular Characterization Using Acidity Specific Markersby Raushan Kumar on April 11, 2024
RESEARCH BACKGROUND: There is considerable diversity in newly developed pummelo × sweet orange citrus hybrids. Most hybrids showed lower peel thickness and high juice yield but there is a lack of information on fruit quality parameters and molecular characterization. Therefore, the aim of the current study is to determine the content of antioxidants and properties of the fresh juice of 24 new pummelo × sweet orange citrus hybrids (Citrus maxima [Burm. f.] Osbeck × Citrus sinensis [L.] […]
- Environmental conditions affect the nutritive value and alkaloid profiles of Lupinus forage: Opportunities and threats for sustainable ruminant systemsby Ana R J Cabrita on April 10, 2024
The identification of crops that simultaneously contribute to the global protein supply and mitigate the effects of climate change is an urgent matter. Lupins are well adapted to nutrient-poor or contaminated soils, tolerate various abiotic stresses, and present relevant traits for acting as ecosystem engineers. Lupins are best studied for their seeds, but their full foraging potential needs further evaluation. This study evaluated the effects of location and sowing date on forage production,…
- Stronger together than apart: The role of social support in adopting a healthy plant-based eating patternby Robin Ortiz on April 10, 2024
The influence of the social environment on health behaviors is well documented. In recent years, there is mounting evidence of the health benefits of a plant-based eating pattern, yet little is known about how the social environment impacts the adoption of a plant-based eating pattern, specifically. In this convergent parallel mixed-methods study, we analyzed quantitative survey data and qualitative focus group data to assess how social support impacted participants of a lifestyle medicine…
- Simultaneous detection of mycotoxins and pesticides in human urine samples: A 24-h diet intervention study comparing conventional and organic diets in Spainby Jose A Gallardo-Ramos on April 10, 2024
Pesticides and mycotoxins, prominent chemical hazards in the food chain, are commonly found in plant-based foods, contributing to their pervasive presence in the human body, as evidenced by biomonitoring programs. Despite this, there is limited knowledge about their co-occurrence patterns. While intervention studies have demonstrated that organic diets can significantly reduce pesticide levels, their impact on mycotoxin exposure has been overlooked. To address this gap, this study pursued two…
- Plant-based meat analogues (PBMAs) and their effects on cardiometabolic health: An 8-week randomized controlled trial comparing PBMAs with their corresponding animal-based foodsby Darel Wee Kiat Toh on April 10, 2024
CONCLUSIONS: A plant-based meat analogues diet did not show widespread cardiometabolic health benefits compared with omnivorous diets over 8 weeks. The composition of PBMAs may need to be considered in future trials.
- Adherence to the Mediterranean diet in two Moroccan populations living at different distances from the Mediterranean Seaby Mohamed Mziwira on April 8, 2024
CONCLUSION: The study data indicate that Mediterranean Diet is far from being a global pattern in this Moroccan population. The study draws attention to the need for a promoting intervention to maintain this pattern as the original diet in the region.